CrossrefInfokarte
Overall Survival Benefit and Long‐Term Safety of Romiplostim in Persistent Chemotherapy‐Induced Thrombocytopenia
American Journal of Hematology · 2026-12 · 101 (12) · 2957-2960
DOI: 10.1002/ajh.70510 ↗Abstract
Kein Abstract verfügbar.
EUVIMED